Those individuals found to have OSA or other evidence of upper airway obstruction (such as chronic mouth breathing) should have an otolaryngology evaluation and, if warranted, adenotonsillectomy prior to starting GH treatment [58]. Here, GH1 is linked to obstructive sleep apnea syndrome.